Skip to main content
Caplight Logo









NeuroAI Inc.

NeuroAI Inc.

Private
FrederictonHealthcare & Life Scienceshttps://neuroai.ca/

Last Round

Grant

Jun 27, 2026

Total Funding Raised

$754,000

Momentum

Top 25%

of companies Caplight tracks

Company Overview

NeuroAI Inc. is a HealthTech company that provides an AI-driven digital platform designed to support neurodevelopmental care for children and their families.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Patient Engagement, NLP & Conversational AI, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

medical AIhealth-techdiagnostic supportpatient engagementAI copilotneurodevelopmental careclinical workflow automationSaaShealthcare analyticsAI health coachdigital healthconversational AIB2B2Cclinical triagevibe coding

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

NeuroAI Inc. Comparables

Compare NeuroAI Inc. with similar companies based on industry and business-model similarity.

NeuroAI Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Cognoa
78%
NovoPsych
69%
BlinkLab Limited
69%

NeuroAI Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJun 27, 2026
GrantMar 18, 2026
SeedApr 9, 2025
GrantNov 18, 2024

Key People

Founding team and executive leadership

Larry Shaw

Co-Founder and Chief Revenue Officer (CRO)

Founding Team

Rageen Rajendram

Co-founder and Chief Medical Officer

Founding Team

Mohammad Anwarul Hoque

Chief Technology Officer

Executive Team

NeuroAI Inc. Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 19, 2026

    Monthly visitors increased 113% MoM, reaching 4K.

  • Mar 18, 2026

    $109K grant received from Kids Brain Health Network.

NeuroAI Inc. Filings

Explore SEC and related filing metadata, where available.

NeuroAI Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about NeuroAI Inc.'s valuation, stock price, and market status.

Is NeuroAI Inc. a public or private company?

NeuroAI Inc. is a private company.

What is the current stock price of NeuroAI Inc.?

NeuroAI Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is NeuroAI Inc. worth (valuation)?

Valuation information for NeuroAI Inc. is not publicly available.

Can I buy NeuroAI Inc. stock?

NeuroAI Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was NeuroAI Inc.'s last funding round?

NeuroAI Inc.'s most recent funding round was Grant on June 27, 2026.

Who are the main investors in NeuroAI Inc.?

Key investors in NeuroAI Inc. include Kids Brain Health Network, New Brunswick Innovation Foundation, National Research Council of Canada, The Firehood.

Will NeuroAI Inc. IPO soon?

No public IPO plans have been announced for NeuroAI Inc..

How can I track NeuroAI Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor NeuroAI Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersFredericton
Employee Range10
Year Founded2023
Last FundingJun 27, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?